{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:25:22Z","timestamp":1782494722611,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20240484538"],"award-info":[{"award-number":["20240484538"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15701-3","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:45:14Z","timestamp":1770619514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of systemic immune-inflammation index and prognostic nutritional index in advanced prostate cancer: development and validation of a comprehensive nomogram"],"prefix":"10.1186","volume":"26","author":[{"given":"Gao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"3","key":"15701_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15701_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853623","volume":"13","author":"FQ Wang","year":"2022","unstructured":"Wang FQ, Wang CC, Xia HF, et al. Burden of prostate cancer in China, 1990-2019: findings from the 2019 Global Burden of Disease Study. Front Endocrinol (Lausanne). 2022;13:853623.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"15701_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"key":"15701_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107932","volume":"228","author":"M Adamaki","year":"2021","unstructured":"Adamaki M, Zoumpourlis V. Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics. Pharmacol Ther. 2021;228:107932.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"15701_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"key":"15701_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865643","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Cao D, Huang Y, et al. The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer. Front Immunol. 2022;13:865643.","journal-title":"Front Immunol"},{"issue":"17","key":"15701_CR7","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.3390\/jcm12175434","volume":"12","author":"HI Ellez","year":"2023","unstructured":"Ellez HI, Keskinkilic M, Semiz HS, et al. The Prognostic Nutritional Index (PNI): a new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma. J Clin Med. 2023;12(17):5434.","journal-title":"J Clin Med"},{"issue":"1","key":"15701_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03924-y","volume":"21","author":"L Meng","year":"2023","unstructured":"Meng L, Yang Y, Hu X, Zhang R, Li X. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med. 2023;21(1):79.","journal-title":"J Transl Med"},{"issue":"1","key":"15701_CR9","first-page":"4","volume":"27","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Wang K, Ou Y, et al. Prognostic value of a baseline prognostic nutritional index for patients with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024;27(1):4\u201313.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"15701_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102142","volume":"22","author":"E Tobing","year":"2024","unstructured":"Tobing E, Tansol C, Tania C, Sihombing AT. Prognostic Nutritional Index (PNI) as independent predictor of poor survival in prostate cancer: a systematic review and meta-analysis. Clin Genitourin Cancer. 2024;22(5):102142.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"15701_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","volume":"18","author":"J Hou","year":"2021","unstructured":"Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 2021;18(5):261\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"15701_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"15701_CR13","first-page":"3735","volume":"27","author":"T Aoyama","year":"2020","unstructured":"Aoyama T, Takano M, Miyamoto M, et al. Pretreatment nutritional status is an independent predictor of chemotherapy-induced leukopenia in esophageal cancer patients. Ann Surg Oncol. 2020;27(10):3735\u201343.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"15701_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/ismej.2015.209","volume":"10","author":"LB Bindels","year":"2016","unstructured":"Bindels LB, Neyrinck AM, Claus SP, et al. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 2016;10(6):1456\u201370.","journal-title":"ISME J"},{"key":"15701_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fonc.2014.00070","volume":"4","author":"T Voron","year":"2014","unstructured":"Voron T, Marcheteau E, Pernot S, et al. Control of the immune response by pro-angiogenic factors. Front Oncol. 2014;4:70.","journal-title":"Front Oncol"},{"issue":"3","key":"15701_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1249\/MSS.0000000000001454","volume":"50","author":"DA Galv\u00e3o","year":"2018","unstructured":"Galv\u00e3o DA, Taaffe DR, Spry N, et al. Exercise preserves physical function in prostate cancer patients with bone metastases. Med Sci Sports Exerc. 2018;50(3):393\u20139.","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"15701_CR17","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1158\/1078-0432.CCR-23-3083","volume":"30","author":"H Cho","year":"2024","unstructured":"Cho H, Byun SS, Son NH, Chung JI, Seo WI, Lee CH, et al. Impact of circulating tumor cell-expressed prostate-specific membrane antigen and prostate-specific antigen transcripts in different stages of prostate cancer. Clin Cancer Res. 2024;30(9):1788\u2013800.","journal-title":"Clin Cancer Res"},{"key":"15701_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107363","volume":"208","author":"G Navarro","year":"2024","unstructured":"Navarro G, G\u00f3mez-Autet M, Morales P, et al. Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling. Pharmacol Res. 2024;208:107363.","journal-title":"Pharmacol Res"},{"issue":"6","key":"15701_CR19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37(6):1000\u201319.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"15701_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796.","journal-title":"NPJ Digit Med"},{"key":"15701_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1037099","volume":"13","author":"T Guo","year":"2022","unstructured":"Guo T, Wang J, Yan S, et al. A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer. Front Endocrinol (Lausanne). 2022;13:1037099.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"15701_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-022-01231-5","volume":"15","author":"X Guan","year":"2022","unstructured":"Guan X, Lu Y, Zhu H, et al. The crosstalk between cancer cells and neutrophils enhances hepatocellular carcinoma metastasis via neutrophil extracellular traps-associated cathepsin G component: a potential therapeutic target. J Hematol Oncol. 2022;15(1):10.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"15701_CR23","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/jcm11092626","volume":"11","author":"M Binder","year":"2022","unstructured":"Binder M, Lengers T, Wirtz DC, et al. Influence of a preoperative nutritional status on outcome in patients undergoing total joint arthroplasty: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2626.","journal-title":"J Clin Med"},{"issue":"9","key":"15701_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/17512433.2017.1347503","volume":"10","author":"JJ Hopkins","year":"2017","unstructured":"Hopkins JJ, Sawyer MB. A review of body composition and pharmacokinetics in oncology. Expert Rev Clin Pharmacol. 2017;10(9):947\u201356.","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15701-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:37:19Z","timestamp":1773830239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15701"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15701-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Beijing Chao-Yang Hospital, Capital Medical University (approval number: 2022-Ke-227). The study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study, and the requirement for written informed consent was waived by the IRB due to the retrospective nature of the study, in accordance with national regulations and institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}